Article
Amendment To The Pricing And Reimbursements Process For Pharmaceuticals
The amendment aims at alleviating the existing regime for pricing of pharmaceuticals for home treatment of chronic, genetic and/or rare diseases and paid by the National Health Insurance Fund

Schoenherr (Schönherr Rechtsanwälte)

